Moolec Science (MLECW) EBT (2022 - 2024)
Moolec Science (MLECW) posted EBT of -$2.1 million for Q4 2024, down 10.44% sequentially from -$1.9 million in Q3 2024, and down 6.28% YoY from -$2.3 million in Q1 2024.
Moolec Science (MLECW) EBT (2022 - 2024) Analysis & Trends
Moolec Science has reported EBT for 3 years, with the latest figure at -$2.1 million in Q4 2024.
- Quarterly EBT fell 6.28% year-over-year to -$2.1 million in Q4 2024, while the trailing twelve-month figure through Dec 2024 was -$8.6 million (down 20.32% YoY) and the FY2024 annual result came in at -$8.4 million, up 83.93% from the prior year.
- EBT retreated to -$2.1 million in Q4 2024 per MLECW's latest filing, from -$1.9 million in the prior quarter.
- Over five years, EBT peaked at $48.0 million in Q4 2022 and troughed at -$3.3 million in Q2 2024.
- A 3-year average of $2.4 million and a median of -$1.7 million in 2022 frame the typical range for EBT.
- The sharpest annual moves came in 2023 and 2024: EBT surged 69.28% in 2023, then plunged 255.65% in 2024.
- Over 3 years, EBT stood at $48.0 million in 2022, then slumped by 104.21% to -$2.0 million in 2023, then declined by 6.28% to -$2.1 million in 2024.
- According to Business Quant data, EBT over the past three periods registered -$2.1 million, -$1.9 million, and -$3.3 million for Q4 2024, Q3 2024, and Q2 2024 respectively.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBT (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.13 Bn | 131.28 Bn | 2.84 Bn | 1.39 Bn |
| 2 | Regeneron Pharmaceuticals | 85.77 Bn | 77.77 Bn | 3.93 Bn | 1.53 Bn |
| 3 | Argenx Se | 64.64 Bn | 59.46 Bn | 1.37 Bn | 541.00 Mn |
| 4 | Moderna | 58.29 Bn | 53.16 Bn | 52.00 Mn | -767.00 Mn |
| 5 | BeOne Medicines | 41.92 Bn | 36.82 Bn | 1.53 Bn | 312.46 Mn |
| 6 | Alnylam Pharmaceuticals | 31.58 Bn | 28.28 Bn | 992.69 Mn | 177.81 Mn |
| 7 | BioNTech SE | 28.12 Bn | 9.73 Bn | 668.28 Mn | -264.70 Mn |
| 8 | Insmed | 27.39 Bn | 26.22 Bn | 358.27 Mn | -11.37 Mn |
| 9 | Royalty Pharma | 27.27 Bn | 26.43 Bn | - | 81.49 Mn |
| 10 | Moolec Science | 8,617.72 | -1.19 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2024 | -2.15 Mn |
| Sep 30, 2024 | -1.94 Mn |
| Jun 30, 2024 | -3.26 Mn |
| Mar 31, 2024 | -1.28 Mn |
| Dec 31, 2023 | -2.02 Mn |
| Sep 30, 2023 | -1.81 Mn |
| Jun 30, 2023 | -2.98 Mn |
| Mar 31, 2023 | -358,578.00 |
| Dec 31, 2022 | 47.96 Mn |
| Sep 30, 2022 | -721,426.00 |
| Jun 30, 2022 | -1.52 Mn |
| Mar 31, 2022 | -1.17 Mn |